Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies
Bordetella respiratory infections are common in people (B. pertussis) and in animals (B.
bronchiseptica). During the last two decades, much has been learned about the virulence …
bronchiseptica). During the last two decades, much has been learned about the virulence …
How best to estimate the global burden of pertussis?
NS Crowcroft, C Stein, P Duclos… - The Lancet infectious …, 2003 - thelancet.com
In most countries, pertussis surveillance is inadequate for accurately estimating numbers of
cases or deaths. Good estimates are needed to help set priorities for vaccination …
cases or deaths. Good estimates are needed to help set priorities for vaccination …
Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage
SW Martin, L Pawloski, M Williams… - Clinical Infectious …, 2015 - academic.oup.com
An analysis assessing for associations between pertactin production and both clinical
presentation and vaccine history found a significant association between vaccination and …
presentation and vaccine history found a significant association between vaccination and …
A search for serologic correlates of immunity to Bordetella pertussis cough illnesses
JD Cherry, J Gornbein, U Heininger, K Stehr - Vaccine, 1998 - Elsevier
In a pertussis vaccine efficacy trial in Germany we collected sera from vaccinees (DTaP or
DTP) after the third and fourth doses of vaccine or at comparable time periods in DT vaccine …
DTP) after the third and fourth doses of vaccine or at comparable time periods in DT vaccine …
Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives
JD Cherry, E Grimprel, N Guiso… - The Pediatric …, 2005 - journals.lww.com
In the past decade, numerous sources have noted an increase in reported pertussis in
highly immunized populations. This has been accompanied by a perceived change in …
highly immunized populations. This has been accompanied by a perceived change in …
Bacterial toxins: friends or foes?
CK Schmitt, KC Meysick, AD O'Brien - Emerging infectious diseases, 1999 - ncbi.nlm.nih.gov
Many emerging and reemerging bacterial pathogens synthesize toxins that serve as primary
virulence factors. We highlight seven bacterial toxins produced by well-established or newly …
virulence factors. We highlight seven bacterial toxins produced by well-established or newly …
Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination
S Baron, E Njamkepo, E Grimprel… - The Pediatric …, 1998 - journals.lww.com
Background. Despite widespread vaccination during 30 years, the hypothesis of a
resurgence of pertussis in France has been raised by outbreaks and sporadic case reports …
resurgence of pertussis in France has been raised by outbreaks and sporadic case reports …
Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan
N Otsuka, HJ Han, H Toyoizumi-Ajisaka, Y Nakamura… - PloS one, 2012 - journals.plos.org
The adhesin pertactin (Prn) is one of the major virulence factors of Bordetella pertussis, the
etiological agent of whooping cough. However, a significant prevalence of Prn-deficient …
etiological agent of whooping cough. However, a significant prevalence of Prn-deficient …
Bordetella pertussis
DJ Nieves, U Heininger - Emerging Infections 10, 2016 - Wiley Online Library
Pertussis is a highly contagious acute respiratory illness classically known as “whooping
cough” because of its characteristic cough. The majority of cases are caused by Bordetella …
cough” because of its characteristic cough. The majority of cases are caused by Bordetella …
Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis
Many countries continue to experience pertussis epidemics despite widespread vaccination.
Waning protection after booster vaccination has highlighted the need for a better …
Waning protection after booster vaccination has highlighted the need for a better …